1Cole PJ.A new look at the pathogenesis,management of persistent bronchial sepsis:a 'vicious circle'hypothesis and its logical therapeutic connotations.In:Davies RJ,editor.Strategies for the management of chronic bronchial sepsis.Oxford:Medicine Publishing Foundation,1984,1-20.
3Pasteur MC,Helliwell SM,Houghton SJ,et al.An investigation into causative factors in patients with bronchiectasis.Am J Respir Crit Care Med,2000,162:1277-1284.
4O'Donnell AE,Barker AF,Ilowite JS,et al.Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I.rhDNase Study Group.Chest,1998,113:1329-1334.
5Bilton D,Henig N,Morrissey B,et al.Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.Chest,2006,130:1503-1510.
6Wallace RJ,Glassroth J,Griffith DE,et al.Diagnosi and treatment of disease caused by nontuberculous mycobacteria.Am J Respir Crit Care Med,1997,156:1-25.
7Stevens DA,Schwartz HJ,Lee JY,et al.A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.N Engl J Med,2000,342:756-762.
8Tsang KW,Ho PI,Chan KN,et al.A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J,1999,13:361-364.
9Rayner CF,Tillotson G,Cole PJ,et al.Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis.J Antimicrob Chemother,1994,34:149-156.
10Stockley RA,Hill SL,Morrison HM.Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state.Thorax,1984,39:414-419.
